Literature DB >> 7264916

Computational problems of compartment models with Michaelis-Menten-type elimination.

C M Metzler, D D Tong.   

Abstract

The Michaelis-Menten equation has been applied successfully in the study of enzyme kinetics. It usually is used to estimate vmax and km from observations of the initial rate of reaction, v, at various substrate concentrations, Cs. A variation of this expression recently was used in pharmacokinetics, where it was assumed that the elimination rate of drug from some compartment is VC(t)/[K + C(t)], where C(t) is the drug concentration. The meaning of V and K in this context is not clear. Attempts were made to estimate V, K, and other model parameters by fitting the model to observed drug concentrations at sampling times after dosing. This paper discusses the ill-conditioning of the estimation of parameters of a differential equation that includes the so-called Michaelis-Menten output. The solution of the equation is bound by the solutions to two first-order differential equations. Parameter values in an infinite region of the parameter space are shown to have solutions also lying within these two bounds. Simulations show that a minor change in the data (observations) or in the initial estimate of the parameters may cause a large change in the final estimates. In many cases, estimation and comparison of parameter values are meaningless.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7264916     DOI: 10.1002/jps.2600700706

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Within- and between-subject variations in pharmacokinetic parameters of ethanol by analysis of breath, venous blood and urine.

Authors:  A Norberg; J Gabrielsson; A W Jones; R G Hahn
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

2.  Estimating potency for the Emax-model without attaining maximal effects.

Authors:  R C Schoemaker; J M van Gerven; A F Cohen
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

3.  A pharmacokinetic model of intravenously administered hyaluronan in sheep.

Authors:  L Lebel; J R Fraser; W S Kimpton; J Gabrielsson; B Gerdin; T C Laurent
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

4.  A tracer interaction method for nonlinear pharmacokinetics analysis: application to evaluation of nonlinear elimination.

Authors:  P Veng-Pedersen; J A Widness; J Wang; R L Schmidt
Journal:  J Pharmacokinet Biopharm       Date:  1997-10

Review 5.  Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.

Authors:  Ake Norberg; A Wayne Jones; Robert G Hahn; Johan L Gabrielsson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  Application of a simplified method to determine bioavailability of an oral dose of phenytoin.

Authors:  A L Davis; E J Begg; M C Kennedy; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1993-04

7.  On the identification of Michaelis-Menten elimination parameters from a single dose-response curve.

Authors:  K R Godfrey; W R Fitch
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

8.  Statistical identifiability and convergence evaluation for nonlinear pharmacokinetic models with particle swarm optimization.

Authors:  Seongho Kim; Lang Li
Journal:  Comput Methods Programs Biomed       Date:  2013-10-22       Impact factor: 5.428

9.  Bioavailability and pharmacokinetics of phenytoin during pregnancy.

Authors:  C M Lander; M T Smith; J B Chalk; C de Wytt; P Symoniw; I Livingstone; M J Eadie
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin.

Authors:  R G Dickinson; W D Hooper; B Wood; C M Lander; M J Eadie
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.